RAD54B as a biomarker for prognosis and immunotherapy response in bladder cancer. Lu Q, Guo J, Xu Y, Cui Y, et al. Discov Oncol 2026 Jan 28. doi: 10.1007/s12672-026-04514.

Read + Share

Amedeo Smart

Independent Medical Education

Lu Q, Guo J, Xu Y, Cui Y, et al. RAD54B as a biomarker for prognosis and immunotherapy response in bladder cancer. Discov Oncol 2026 Jan 28. doi: 10.1007/s12672-026-04514.
PMID: 41606132